LOINC
Version 2.73

LP14719-6glipiZIDEActive

Descriptions

LP14719-6   glipiZIDE
An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. Source: National Library of Medicine, MeSH 2006

LP14719-6   glipiZIDE
Sulfonylurea (UK: Sulphonylurea) derivatives are antidiabetic drugs primarily used to treat diabetes mellitus type 2, and include drugs such as Chlorpropamide, Tolazamide, Tolbutamide, Glyburide, Gliclazide, Glipizide, Gliquidone, Acetohexamide and others. They act by increasing insulin release from the beta cells in the pancreas. Sulfonylureas are ineffective where there is absolute deficiency of insulin production such as in type 1 diabetes or post-pancreatectomy. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Sulfonylureas

Basic Part Properties

Name
glipiZIDE
Type
Component
Created On
2000-05-04
Construct for LOINC Short Name
glipiZIDE

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP14719-6

Language Variants Get Info

zh-CNChinese (China)
格列甲嗪
nl-NLDutch (Netherlands)
glipizide
et-EEEstonian (Estonia)
Glipisiid
fr-BEFrench (Belgium)
Glipizide
fr-CAFrench (Canada)
Glipizide
it-ITItalian (Italy)
Glipizide
ru-RURussian (Russian Federation)
Глипизид
es-ESSpanish (Spain)
Glipizida
tr-TRTurkish (Turkey)
Glipizid